ClinVar Miner

Submissions for variant NM_000252.2(MTM1):c.231+1G>A (rs587783810)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000146435 SCV000193722 pathogenic Severe X-linked myotubular myopathy 2013-02-08 criteria provided, single submitter clinical testing
GeneDx RCV000254869 SCV000322635 pathogenic not provided 2017-02-07 criteria provided, single submitter clinical testing The c.231+1G>A pathogenic variant in the MTM1 gene has not been reported previously as apathogenic variant nor as a benign variant, to our knowledge. It is reported as pathogenic in ClinVarby a different clinical laboratory, but additional evidence is not available (ClinVar SCV000193722.1;Landrum et al., 2015). This splice site variant destroys the canonical splice donor site in intron 4. It ispredicted to cause abnormal gene splicing, either leading to an abnormal message that is subject tononsense-mediated mRNA decay, or to an abnormal protein product if the message is used for proteintranslation. The c.231+1G>A variant was not observed in approximately 6500 individuals ofEuropean and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is nota common benign variant in these populations.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.